Skip to main content
Premium Trial:

Request an Annual Quote

SkylineDx, VIB Form Molecular Diagnostics Partnership

NEW YORK — SkylineDx said on Wednesday that it is collaborating with Belgian life science research institute VIB to develop novel molecular diagnostics for unmet medical needs.

According to SkylineDx, the three-year partnership will bring together VIB's single-cell analysis and biomarker discovery expertise with SkylineDx's global network of clinical centers and physicians, as well as its diagnostic development and commercialization know-how.

The alliance will focus on high-potential in vitro diagnostic opportunities for unmet medical needs for global markets, SkylineDx said. Financial and other terms of the deal were not disclosed.

Rotterdam-based SkylineDx currently markets the Merlin assay, which is designed to predict the risk of metastasis in a patient's sentinel lymph nodes, and the MMprofiler test for multiple myeloma prognosis. Both are available as CE-IVD-marked kits in Europe and as CLIA-validated laboratory-developed tests in the US. It also offers a biomarker discovery service.

In early 2020, SkylineDx began working with BioInvent International to characterize predictive immunological signatures for cancer.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.